Diversified Trust Co raised its position in shares of Dentsply International Inc. (NASDAQ:XRAY) by 12.4% during the second quarter, Holdings Channel reports. The firm owned 4,987 shares of the company’s stock after buying an additional 550 shares during the period. Diversified Trust Co’s holdings in Dentsply International were worth $309,000 at the end of the most recent reporting period.
Several other large investors have also modified their holdings of XRAY. BlueMountain Capital Management LLC acquired a new stake in shares of Dentsply International during the first quarter worth approximately $953,000. HBK Investments L P acquired a new stake in shares of Dentsply International during the first quarter worth approximately $512,000. Squarepoint Ops LLC boosted its stake in shares of Dentsply International by 131.0% in the first quarter. Squarepoint Ops LLC now owns 35,475 shares of the company’s stock worth $2,186,000 after buying an additional 20,116 shares during the period. Geode Capital Management LLC boosted its stake in shares of Dentsply International by 74.3% in the first quarter. Geode Capital Management LLC now owns 2,038,189 shares of the company’s stock worth $125,389,000 after buying an additional 868,611 shares during the period. Finally, Envestnet Asset Management Inc. boosted its stake in shares of Dentsply International by 140.7% in the first quarter. Envestnet Asset Management Inc. now owns 71,913 shares of the company’s stock worth $4,432,000 after buying an additional 42,040 shares during the period. Institutional investors and hedge funds own 94.58% of the company’s stock.
Dentsply International Inc. (NASDAQ:XRAY) traded down 0.91% on Thursday, hitting $59.10. 1,646,609 shares of the stock traded hands. Dentsply International Inc. has a 12-month low of $49.48 and a 12-month high of $65.83. The firm’s 50-day moving average price is $60.33 and its 200-day moving average price is $61.46.
Dentsply International (NASDAQ:XRAY) last released its quarterly earnings data on Friday, August 5th. The company reported $0.76 EPS for the quarter, topping the consensus estimate of $0.70 by $0.06. Dentsply International had a net margin of 11.99% and a return on equity of 9.18%. The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. During the same period in the previous year, the firm earned $0.73 EPS. The business’s revenue for the quarter was up 46.4% compared to the same quarter last year. On average, equities analysts expect that Dentsply International Inc. will post $2.76 earnings per share for the current fiscal year.
The firm also recently disclosed a dividend, which will be paid on Friday, October 14th. Investors of record on Friday, September 30th will be given a $0.0775 dividend. The ex-dividend date of this dividend is Wednesday, September 28th. Dentsply International’s dividend payout ratio is presently 14.49%.
Several equities research analysts recently issued reports on XRAY shares. Bank of America Corp. started coverage on shares of Dentsply International in a research report on Monday, September 12th. They set a “buy” rating and a $70.00 price objective for the company. Credit Suisse Group AG restated a “buy” rating on shares of Dentsply International in a research report on Sunday, June 5th. JPMorgan Chase & Co. started coverage on shares of Dentsply International in a research report on Thursday, September 22nd. They set a “neutral” rating and a $65.00 price objective for the company. Zacks Investment Research cut shares of Dentsply International from a “buy” rating to a “hold” rating in a research report on Monday, August 8th. Finally, Piper Jaffray Cos. restated a “buy” rating on shares of Dentsply International in a research report on Monday, June 27th. Six analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $66.82.
In related news, SVP Maureen J. Macinnis sold 17,650 shares of the business’s stock in a transaction dated Tuesday, August 23rd. The shares were sold at an average price of $60.61, for a total value of $1,069,766.50. Following the sale, the senior vice president now directly owns 19,630 shares in the company, valued at approximately $1,189,774.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Maureen J. Macinnis sold 45,100 shares of the business’s stock in a transaction dated Thursday, August 25th. The stock was sold at an average price of $60.55, for a total transaction of $2,730,805.00. Following the completion of the sale, the senior vice president now owns 36,730 shares in the company, valued at $2,224,001.50. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by corporate insiders.
Dentsply International Company Profile
DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dentsply International Inc. (NASDAQ:XRAY).
Receive News & Ratings for Dentsply International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply International Inc. and related companies with MarketBeat.com's FREE daily email newsletter.